Trial intelligence / Profile preview

Phase 3 trial of trafermin spray for neuropathic diabetic foot ulcer

NL-OMON38005Phase 3Recruiting

Sponsor
Olympus
Start
Aug 2011
Modality
Recombinant Proteins and Enzymes
Countries
1
01

Overview

A Phase 3 trial of trafermin in diabetic foot ulcer (DFU), sponsored by Olympus. Started Aug 2011; status: recruiting.

02

Drugs

trafermin
03

Conditions

diabetic foot ulcer (DFU)

Beyond the preview

Go deeper on NL-OMON38005.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NL-OMON38005.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call